147 related articles for article (PubMed ID: 11463304)
1. Design and synthesis of unsymmetrical peptidyl urea inhibitors of aspartic peptidases.
Dales NA; Bohacek RS; Satyshur KA; Rich DH
Org Lett; 2001 Jul; 3(15):2313-6. PubMed ID: 11463304
[TBL] [Abstract][Full Text] [Related]
2. Aspartic protease inhibitors designed from computer-generated templates bind as predicted.
Ripka AS; Satyshur KA; Bohacek RS; Rich DH
Org Lett; 2001 Jul; 3(15):2309-12. PubMed ID: 11463303
[TBL] [Abstract][Full Text] [Related]
3. From peptides to non-peptide peptidomimetics: design and synthesis of new piperidine inhibitors of aspartic peptidases.
Bursavich MG; West CW; Rich DH
Org Lett; 2001 Jul; 3(15):2317-20. PubMed ID: 11463305
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the interaction between the aspartic peptidase inhibitor SQAPI and aspartic peptidases using surface plasmon resonance.
Farley PC; Christeller JT; Sullivan ME; Sullivan PA; Laing WA
J Mol Recognit; 2002; 15(3):135-44. PubMed ID: 12203839
[TBL] [Abstract][Full Text] [Related]
5. Nonspecific electrostatic binding of substrates and inhibitors to porcine pepsin.
Kuzmic P; Sun CQ; Zhao ZC; Rich DH
Adv Exp Med Biol; 1991; 306():75-86. PubMed ID: 1812761
[No Abstract] [Full Text] [Related]
6. X-ray crystallographic studies of the complex between porcine pepsin and the aspartic proteinase inhibitor PI-3 from the nematode Ascaris suum.
Petersen JF; Chernaia MM; Rao-Naik C; Zalatoris JL; Dunn BM; James MN
Adv Exp Med Biol; 1998; 436():391-5. PubMed ID: 9561247
[No Abstract] [Full Text] [Related]
7. An analysis of subdomain orientation, conformational change and disorder in relation to crystal packing of aspartic proteinases.
Bailey D; Carpenter EP; Coker A; Coker S; Read J; Jones AT; Erskine P; Aguilar CF; Badasso M; Toldo L; Rippmann F; Sanz-Aparicio J; Albert A; Blundell TL; Roberts NB; Wood SP; Cooper JB
Acta Crystallogr D Biol Crystallogr; 2012 May; 68(Pt 5):541-52. PubMed ID: 22525752
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, SAR, and X-ray structure of human BACE-1 inhibitors with cyclic urea derivatives.
Park H; Min K; Kwak HS; Koo KD; Lim D; Seo SW; Choi JU; Platt B; Choi DY
Bioorg Med Chem Lett; 2008 May; 18(9):2900-4. PubMed ID: 18434152
[TBL] [Abstract][Full Text] [Related]
9. X-ray structures of retroviral proteases and their inhibitor-bound complexes.
Ringe D
Methods Enzymol; 1994; 241():157-77. PubMed ID: 7854176
[No Abstract] [Full Text] [Related]
10. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.
Ng KK; Petersen JF; Cherney MM; Garen C; Zalatoris JJ; Rao-Naik C; Dunn BM; Martzen MR; Peanasky RJ; James MN
Nat Struct Biol; 2000 Aug; 7(8):653-7. PubMed ID: 10932249
[TBL] [Abstract][Full Text] [Related]
11. A new way of looking at aspartic proteinase structures: a comparison of pepsin structure to other aspartic proteinases in the near active site region.
Andreeva NS; Bochkarev A; Pechik I
Adv Exp Med Biol; 1995; 362():19-32. PubMed ID: 8540318
[No Abstract] [Full Text] [Related]
12. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
[TBL] [Abstract][Full Text] [Related]
13. Structure-function database for active site binding to the aspartic proteinases.
Rao C; Scarborough PE; Lowther WT; Kay J; Batley B; Rapundalo S; Klutchko S; Taylor MD; Dunn BM
Adv Exp Med Biol; 1991; 306():143-7. PubMed ID: 1812702
[No Abstract] [Full Text] [Related]
14. Structure and mechanism of the pepsin-like family of aspartic peptidases.
Dunn BM
Chem Rev; 2002 Dec; 102(12):4431-58. PubMed ID: 12475196
[No Abstract] [Full Text] [Related]
15. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.
Hartman AM; Mondal M; Radeva N; Klebe G; Hirsch AK
Int J Mol Sci; 2015 Aug; 16(8):19184-94. PubMed ID: 26287174
[TBL] [Abstract][Full Text] [Related]
17. Aspartic proteases in drug discovery.
Eder J; Hommel U; Cumin F; Martoglio B; Gerhartz B
Curr Pharm Des; 2007; 13(3):271-85. PubMed ID: 17313361
[TBL] [Abstract][Full Text] [Related]
18. Conformation analysis of non-pepsin-type acid proteinase A from the fungus Aspergillus niger by NMR.
Kojima M; Tanokura M; Muto Y; Miyano H; Suzuki E; Hamaya T; Takizawa T; Kono T; Takahashi K
Adv Exp Med Biol; 1995; 362():611-5. PubMed ID: 8540381
[No Abstract] [Full Text] [Related]
19. Overcoming the unfavourable entropic contribution of ligand binding with a macrocyclic inhibitor bound to penicillopepsin.
Fraser ME; Meyer JH; Bartlett PA; James MN
Adv Exp Med Biol; 1998; 436():355-9. PubMed ID: 9561242
[No Abstract] [Full Text] [Related]
20. A new type of aspartic proteinase inhibitors with a symmetric structure.
Tarasova NI; Gulnik SV; Prischenko AA; Livantsov MV; Lysogorskaya EN; Oksenoit ES
Adv Exp Med Biol; 1991; 306():539-42. PubMed ID: 1812755
[No Abstract] [Full Text] [Related]
[Next] [New Search]
